Cardiovascular impact of electronic-cigarette use

Area of Science:

• Cardiovascular science
• Tobacco regulatory science
• Public health

Background:

• Cardiovascular disease is a leading cause of premature death from traditional cigarettes (TCs).
• Electronic cigarettes (ECs) have rapidly gained popularity in the tobacco product market.
• Understanding the cardiovascular impact of ECs is crucial for public health.

Purpose of the Study:

• To review the cardiovascular impact of electronic cigarettes (ECs).
• To assess cardiovascular risk biomarkers associated with EC use compared to TC smoking.
• To inform cessation strategies and public health messaging regarding ECs.

Main Methods:

• Review of existing biomarker studies on EC users.
• Comparison of cardiovascular risk markers between EC users and TC smokers.
• Analysis of markers for sympathetic nerve activity, oxidative stress, inflammation, vascular dysfunction, and thrombosis.

Main Results:

• Biomarkers indicating increased cardiovascular risk have been observed after EC use.
• These abnormal biomarkers are often less pronounced in EC users than in TC smokers.
• Longitudinal studies are needed to determine long-term cardiovascular disease risk in chronic EC users.

Conclusions:

• ECs may be a viable smoking cessation tool for individuals who have failed other FDA-approved methods.
• However, ECs are not harmless and pose cardiovascular risks.
• Non-smokers, especially young people, should not initiate EC use due to potential health harms.